TSBX - Turnstone Biologics Corp.
0.355
0.005 1.408%
Share volume: 283,774
Last Updated: 08-08-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.35
0.01
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | |
| Report Date | 05-13-2024 | 08-14-2024 | 11-12-2024 | 05-08-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 20.691 M | 22.057 M | 18.368 M | 9.164 M | |
| Selling general and admin | 4.901 M | 4.327 M | 3.944 M | 4.807 M | |
| Research and development | 15.790 M | 17.730 M | 14.424 M | 4.357 M | |
| Total expenses | 20.691 M | 22.057 M | 18.368 M | 9.164 M | |
| 6.60% | -16.72% | -50.11% | |||
| Operating income | -20.691 M | -22.057 M | -18.368 M | -9.164 M | |
| Ebit | -20.691 M | -21.302 M | -17.848 M | -11.804 M | |
| Pretax income | -19.613 M | -21.302 M | -17.848 M | -11.804 M | |
| 8.61% | -16.21% | -33.86% | |||
| Income tax | 16.000 K | 2.000 K | -816.000 K | 2.000 K | |
| Net income basic | -19.629 M | 0.000 | 0.000 | 0.000 | |
| 100.00% | |||||
| Net income | -19.629 M | -21.304 M | -17.032 M | -11.806 M | |
| -8.53% | 20.05% | 30.68% |